1. Fitzgerald KA, Kagan JC. Toll-like Receptors and the Control of Immunity. Cell. 2020;180:1044—1066. doi:10.1016/j.cell.2020.02.041
2. Gioannini TL, Teghanemt A, Zhang D, Coussens NP, Dockstader W, Ramaswamy S, et al. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc Natl Acad Sci USA. 2004;101:4186-4191. doi:10.1073/pnas.0306906101
3. Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, et al. PD-1 expression by macropliages plays a pathologic role in altering microbial clearance and tlie innate inflammatory response to sepsis. Proc Natl Acad Sci USA. 2009; 106: 6303-6308. doi:10.1073/pnas.0809422106
4. Schuetz P. Castro P, Shapiro NI. Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care. 2011;34: 771-778. doi:10.2337/de 10-1185
5. Frydrych LM, Bian G, O,Lone DE, Ward PA, Delano MJ. Obesity and type 2 diabetes mellilus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 20l8;104: 525-534. doi:10.1002/JLB.5VMR0118-021RR
6. Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, et al. Mortality from infectious diseases in diabetes. Nutr Metab Cardiovasc Dis. 2018;28: 444-450. doi:10.1016/J.NUMECD.2017.12.007
7. Biswas SK,Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009;30: 475-487. doi:10.1016/j.it.2009.07.009
8. Andreasen AS, Pedersen-Skovsgaard T, Berg RMG, Svendsen KD, Feldt-Rasmussen B. Pedersen BK, et al. Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia. Intensive Care Med. 2010;36: 1548-1555. doi:10.1007/s00134-010-1845-1
9. Creely SJ, McTeman PG, Kusminski CM, Fisher ff. M, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Metab. 2007;292: E740-E747. doi:10.1152/ajpendo.00302.2006
10. Gomes JMG, Costa J de A, Alfenas R de CG. Metabolic endotoxemia and diabetes mellitus: A systematic review. Metabolism. 2017;68: 133-144. doi:10.1016/j .metab01.2016.12.009
11. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E,Delaney V, et al. Advanced Glycosylation End Products in Patients with Diabetic Nephropathy. N Engl J Med. 1991;325: 836-842. doi:10.1056/NEJM199109193251202
12. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 1992;267: 5133-5138.
13. Takeuchi M, Takino J, Yamagishi S.Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Targets. 2010;!!:1468-1482. doi:10.2174/1389450111009011468
14. Byun K. Yoo Y,Son M,Lee J,Jeong G-B, Park YM, et al. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol Ther. 2017;177: 44-55. doi:10.1016?j.pharmthera.2017.02.030
15. Hamasaki S, Kobori T, Yamazaki Y, Kitaura A, Niwa A, Nishinaka T, et al. Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis. Sci Rep. 2018;8: 5901. doi:10.1038/s41598-018-24325-y
16. Uhle F, Weiterer S,Siegler BH,Brenner T. Lichtenstem C, Weigand MA. Advanced glycation endproducts induce self· and cross-tolerance in monocytes. Inflamm Res. 2017;66: 961 968. doi:10.1007/s00011-017-1076-9
17. Miki Y, Dambara II. Tachibana Y, Ilirano K, Konishi M, Beppu M. Macrophage recognition of toxic advanced glycosylation end products through the macrophage surface-receptor nucleolin. Biol Phann Bull. 2014:37: 588-596. Available: http://www.ncbi.nlm.nih.gov/pubmed/24818254
18. Ayelign B, Negash M, Genetu M,Wondmagegn T, Shibabaw T. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019: 6196532. doi:10.1155/2019/6196532
19. Miinch G, Keis R, Wessels A, Riederer P, Bahner U, Heidland A, et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem. 1997;35: 669-677. doi:10.1515/cclm. 1997.35.9.669
20. Liu AP, Aguet F, Danuser G, Schmid SL. Local clustering of transferrin receptors promotes clathrin-coated pit initiation. J Cell Biol. 2010;191: 1381-1393. doi:10.1083/jcb.201008117
21. Kaksonen M, Roux A. Mechanisms of clatlirin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018;19:313-326. doi:10.1038/nrm.2017.132
22. Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol. 2003; 161: 673-677. doi:10.1083/jcb.200302028
23. Kovtun O, Tillu VA, Ariotti N, Parton RG, Collins BM. Cavin family proteins and the assembly of caveolae. J Cell Sci. 2015;128: 1269-1278. doi:10.1242/jcs. 167866
24. Dunzendorler S, Lee H-K, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol. 2004; 173: 1166-1170. doi:10.4049/jimmunol.173.2.1166
25. Borz^cka K, Plociennikowska A, Bjorkelund H, Sobota A, Kwiatkowska K. CD14 mediates binding of high doses of LPS but is dispensable for TNF-α production. Mediators Inflamm. 2013;2013: 824919. doi:10.1155/2013/824919
26. Adachi Y, Satokawa C, Saeki M, Ohno N, Tamura H, Tanaka S, et al. Inliibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages. J Endotoxin Res. 1999;5:139-146. doi:10.1177/09680519990050030701
27. Tebo JM, Kim HS, Gao J, Armstrong DA, Hamilton TA. Interleukin-10 Suppresses IP-10 Gene Transcription by Inhibiting die Production of Class I Interferon. Blood. 1998;92: 4742-4749. doi:10.1182/blood.V92.12.4742
28. Czerkies M. Borz^cka K, Zdioruk MI, Pldciennikowska A, Sobota A, Kwiatkowska K. An interplay between scavenger receptor A and CD14 during activation of J774 cells by high concentrations of LPS. Immunobiology. 2013:218: 1217-1226. doi:10.1016/j.imbio.2013.04.005
29. Takahashi HK, Mori S, Wake H, Liu K, Yoshino T, Ohashi K, et al. Advanced glycation end products subspecies-selectively induce adhesion molecule expression and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Exp Ther. 2009;330: 89-98. doi:10.1124/jpet.109.150581
30. Jin X, Yao T, Zhou Z, Zhu J, Zhang S. Hu W, et al. Advanced Glycation End Products Enhance Macrophages Polarization into Ml Phenotype tlirough Activating RAGE/NF-κΒ Pathway. Biomed Res Int. 2015;2015: 732450. doi: 10.1155/2015/732450
31. Hudson BI, Lippman ME. Targeting RAGE Signaling in Inflammatory Disease. Annu Rev Med. 2018;69: 349-364. doi:10.1146/annurev-med-041316-085215
32. Hodgkinson CP, Laxton RC, Patel K, Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Tliromb Vase Biol. 2008;28: 2275-2281. doi:10.1161 /AT VB AH A. 108.175992
33. Niven J, Hoare J, McGowan D, Devaraj an G,Itohara S. Gannage M,et al. SIOOB Up-Regulates Macrophage Production of ILlp and CCL22 and Influences Severity of Retinal Inflammation. Lewin AS, editor. PLoS One. 2015;10: eOl32688. doi:10.1371/joumal.pone.0132688
34. Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19: 734-746. doi:10.1038/s41577-019-0213-9
35. Kantennan J, Sade-Feldman M, Baniyash M. New insights into clironic inflammation-induced immunosuppression. Semin Cancer Biol. 2012;22: 307-318. doi:10.1016/J.SEMCANCER.2012.02.008
36. Snell LM, McGaha TL, Brooks DG. Type I Interferon in Chronic Virus Infection and Cancer. Trends Immunol. 2017;38: 542-557. doi:10.1016/J.IT.2017.05.005
37. Watanabe M, Toyomura T, Wake II, Liu K, Teshigawara K, Takahashi II, et al. Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells. Bioteclinol Appl Biochem. 2020;67: 265-272. doi:10.1002/bab.1843
38. Fukumoto S, Hiroi M, Dirgahayu P, Miura K, Tademoto S, Otsuki H, et al. Suppression of IP-10/CXCL10 gene expression in LPS- and/or IFN-y-stimulated macrophages by parasite-secreted products. Cell Immunol. 2012;276: 101-109. doi: 10.1016/j.cellimm.2012.04.007
39. Walley KR, Thain KR, Russell JA, Reilly MP, Meyer NJ, Ferguson JF, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Sci Trans 1 Med. 2014;6: 258ral43. doi:10.1126/scitranslmed.3008782
40. Cheng N, Liang Y, Du X, Ye RD. Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep. 2018;19: e45517. doi:10.15252/embr.201745517
41. Zanoni 1,Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol. 2013;3: 32. doi:10.3389/fcimb.2013.00032
42. Kim S, Kim SY, Pribis JP, Lotze M, Mollen KP, Shapiro R, et al. Signaling ofHigh Mobility Gro 叩 Box 1(HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD 14. Mol Med. 2013;19: 88-98. doi: 10.2119/molmed.2012.00306
43. Vasselon T, Hailman E, Thieringer R, Detmers PA. Internalization of monomeric lipopolysaccharide occurs after transfer out of cell surface CD 14. J Exp Med. 1999; 190: 509-521. doi:10.1084/jem. 190.4.509
44. Cowan DB, Noria S, Stamm C, Garcia LM, Poutias DN, del Nido PJ, et al. Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes. Circ Res. 2001 ;88: 491-498. doi:10.1161/01.res.88.5.491
45. Tan Y, Zanoni I,Cullen TW, Goodman AL, Kagan JC. Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria. Immunity. 2015;43: 909-922. doi:10.1016/J.IMMUNI.2015.10.008
46. Chen Z, Shao Z, Mei S, Yan Z, Ding X,Billiar T, et al. Sepsis Upregulates CD14 Expression in a MyD88-Dependent and Trif-lndependent Pathway. Shock. 2018;49: 82-89. doi:10.1097/SHK.0000000000000913
47. Jafar N, Edriss H, Nugent K. The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am J Med Sci. 2016;351: 201-211.doi:10.1016/j.amjms.2015.11.011
48. Cantuaria APC, Figueiredo TM, Freire MS, Lima SMF, Almeida J A, Franco OL, et al. The effects of glucose concentrations associated with lipopolysaccharide and interferon-gamma stimulus on mediators' production of RAW 264.7 cells. Cytokine. 2018;107: 18-25. doi:10.1016/j .cyto.2017.11.008